StockData

Neo-Concept International vs Ping An Biomedical

NCI and PASW side by side, both in apparel and other finished products made from fabrics and similar materials. Figures are trailing twelve months unless noted, from SEC filings and end-of-day prices.

How NCI and PASW compare

Neo-Concept International grew revenue faster over the last twelve months (−41.8% versus −61.0% for Ping An Biomedical).

Neo-Concept International keeps more of each dollar of sales as profit, with a net margin of 0.24% compared with −37.6% at Ping An Biomedical.

Neo-Concept International scores higher on the StockData Score (6 against 2 for Ping An Biomedical), which adds up 30 checks on valuation, growth, past performance, financial health and dividends.

Key numbers

A dot marks the better figure where higher or lower is clearly better.

MetricNCIPASW
Size and price
Share price$4.92$1.42
Change, 1 year−92.8%−94.3%
Change, 5 years−99.9%–
Employees–7
StockData Score
Total score6 (better)2
Valuation score00
Growth score1 (better)0
Performance score00
Health score5 (better)2
Dividend score00
Growth
Revenue growth (TTM)−41.8% (better)−61.0%
Net income growth (TTM)−95.9%–
EPS growth (TTM)−96.1%–
Profitability
Gross margin36.9% (better)2.8%
Operating margin1.3% (better)−43.1%
Net margin0.24% (better)−37.6%
FCF margin12.7%–
Return on equity0.41% (better)−38.6%
Return on invested capital1.1% (better)−29.2%
Financial health
Debt / equity0.000.13 (better)
Net debt / EBITDA−5.59–
Interest coverage–−47.9×
Current ratio4.29 (better)2.54
Piotroski F-score6 (better)3
Ownership
Held by institutions3.1%–
Held by insiders74.9%10.3%

Go deeper

For information only, not investment advice. Check the source filings before relying on any figure.